Join
Live feed
·
PRReleasevia Quantisnow
Halozyme Therapeutics Inc. logo
Incyte Corp. logo

Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA033989 Using its ENHANZE® Technology

ByQuantisnow·Wall Street's wire, on your screen.
HALO· Halozyme Therapeutics Inc.INCY· Incyte Corp.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HALO (Halozyme Therapeutics Inc.), INCY (Incyte Corp.) and more on Quantisnow.

Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA033989 Using its ENHANZE® Technology | Quantisnow